The presence of a high incidence of thrombotic events, mainly in nontransfusion-dependent β-thalassemia syndromes, has led to the identification of a hypercoagulable state in thalassemia patients. This article highlights the mechanisms leading to hypercoagulability in thalassemia. It also discusses the clinical experience and available evidence on prevention and management approaches.
Keywords: Cerebrovascular disease; Hypercoagulable state; Pulmonary hypertension; Thrombosis.
Copyright © 2017 Elsevier Inc. All rights reserved.